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Fact file on NSTE-ACS, Atherosclerosis and 
Cardiovascular Risk Factors
Acute coronary syndromes (ACS) affect around 
1 million patients annually in the USA, and 
around 75% of these patients are diagnosed 
with non-ST elevation-ACS: unstable angina 
or NSTEMI. (Hedayati et al., 2018). These two 
conditions share a similar pathophysiology 
but NSTEMI is differentiated from unstable 
angina since in NSTEMI, the levels of cardiac 
troponin are higher than the 99th percentile of 
the upper reference limit for the normal range 
of the assay. (ESC, Fourth universal definition of 
myocardial infarction (2018).
This case presents a very important dilemma 
for a casualty physician: determining the cause 
of chest pain. The determination of aetiology 
was complicated by the fact that the patient 
also suffered from gastro-oesophageal reflux 
disease (GORD). Due to the fact that visceral 
pain pathways of the stomach/oesophagus and 
the heart are shared, the referred pain from 
these organs can give very similar symptoms.
The pathophysiology of NSTEMI entails 
mismatch between myocardial oxygen supply 
and demand: there is subendocardial ischaemia 
where the atherothrombosis is causing partial 
blood flow obstruction. As with the other acute 
coronary syndromes, NSTEMI is the result of 
the inflammatory process of atherosclerosis and 
occurs most commonly due to plaque erosion 
with an intact fibrous cap (Basit et al., 2019; 
Puymirat et al., 2019). 
Mr A.N., a 59-year-old male, was referred to 
casualty by a health centre physician, following 
the complaint of two episodes of worsening 
exertional chest pain. He is a known case of 
hypertension, non-insulin-dependent diabetes 
mellitus and smokes 1 pack of cigarettes daily. 
Following appropriate investigations such as 
electrocardiogram (ECG), cardiac biomarkers 
and echocardiography, the patient was 
diagnosed with non-ST elevation myocardial 
infarction (NSTEMI). The patient is now 
stable on treatment; however, his overall 
cardiovascular risk remains high due to factors 
such as smoking, uncontrolled type 2 diabetes, 
hypertension and hypercholesterolaemia. This 
case highlights the importance of measuring 
global cardiovascular risk since this has 
important treatment and follow-up implications; 
importantly, ischaemic heart disease can be 
primarily or secondarily prevented through non-
pharmacological or pharmacological alteration 
of the cardiovascular risk factors.
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The other major important clinical point 
pertaining to this case is the presence of 
cardiovascular risk factors which determine 
treatment in the form of early invasive therapy. 
This patient had a HEART score of 8, indicating 
high risk and a need for urgent invasive 
intervention. The HEART score table (Hedayati 
et al., 2018) shown in figure 2 is a useful tool in 
stratification and management of patients with 
ACS. 
Presenting Complaint
The patient was referred to A&E after he 
experienced two episodes of diffuse chest pain 
of an intermittent nature. 
History of Presenting Complaint 
The first episode occurred when the patient 
was at work: he had exerted himself by 
climbing some stairs and a ladder when he 
experienced a deep compressive pain in his 
chest which lasted 10 minutes. The second 
episode occurred three days later and lasted 
for around 15 minutes, and was described as 
centrally compressive chest pain associated 
with diaphoresis. There was no vomiting or loss 
of consciousness during either episode, but the 
patient complained of sensations of nausea. 
The patient was unable to pinpoint the precise 
site of the pain: the pain was of a diffuse nature 
throughout his chest. The patient had been 
suffering from chest pains of varying nature for 
10 years; these have been found to be a mixture 
of stable angina and pain due to GORD. 
However, these two particular episodes of 
chest pain were different from the other chronic 
episodes since the character of the pain was 
more compressive, caused more shortness of 
breath and was of higher severity. The patient 
denied any radiation of the pain to the left arm, 
right arm, jaw or neck. This pain was associated 
with sweating and nausea but not fever. In both 
episodes, the pain lasted for 15 minutes or less 
and was intermittent. Cold temperatures and 
exertion exacerbated the severity of the pain, 
which the patient grades as 7 out of 10. 
Past Medical and Surgical History 
The patient is a known case of type II diabetes 
mellitus and hypercholesterolaemia. During 
the last year his diabetes has not been well-
controlled and the patient admits to not 
taking medications for his elevated cholesterol 
levels. Coupled with other non-modifiable risk 
factors such as genetic predisposition, age 
and male gender, these modifiable risk factors 
contributed to this acute coronary syndrome. 
The patient also has a 10-year history of GORD 
which he states was mainly triggered by stress.
The patient had a minor operation to remove a 
benign skin lesion 10 years ago. 
Importantly, the patient had experienced a 
variety of chest pains throughout the last 10 
years: these may be of cardiac origin or due 
to GORD. The patient had never had an acute 
coronary event, coronary artery bypass grafting 
(CABG) or percutaneous coronary intervention 
(PCI) before.
Drug History and Allergies
Patient has no known drug allergies. His drug 
history is listed in table 1. An important factor, 
as previously discussed, is that the patient was 
poorly compliant to prescribed medications.
35 MINIMA
Family History
The patient’s mother had a history of type II 
diabetes mellitus and hypertension, but did not 
die due to a cardiovascular event. His father 
had a history of heart failure and died aged 82. 
None of his siblings have experienced an acute 
cardiovascular event. 
Social History
The patient is married and lives at home with 
his wife and daughter. He is independent and 
his occupation entails a certain degree of 
manual labour. His condition might now restrict 
him from continuing his usual work. 
Importantly, given that smoking is an 
independent risk factor for cardiovascular 
disease, the patient has smoked 10-15 
cigarettes per day since around the age of 20, 
which equates to 39 pack years.The patient only 
drinks alcohol socially. 
Systemic Enquiry
• General health: overall the patient is healthy, 
however he has a number of cardiovascular 
risk factors and is also quite stressed
• Cardiovascular system: 
hypercholesterolaemia, hypertension, no 
palpitations
• Respiratory system: no shortness of breath 
(SOB) at rest, SOB occurred during episodes 
of chest pain
• Gastrointestinal tract: dyspepsia 
• Genitourinary system: pt has no problems 
passing urine, feels no burning sensation
• Musculoskeletal system: nil to note
• Endocrine system: nil to note
Differential Diagnosis
1. ACS (ECG points towards NSTEMI, 
diagnosis pending troponin result)
2. Chest pain due to severe GORD (unlikely)
3. Musculoskeletal pain e.g. costochondritis 
(highly unlikely)
4. Pulmonary embolism due to the presence 
of right bundle branch block on the ECG. 
There were no older ECGs to compare with 
and check whether this is an old or new right 
bundle branch block.
(Nature of the pain meant that pericarditis was 
very unlikely).
Diagnostic Investigations
1. Investigation: 12-lead ECG
2. Justification: ECG is essential in diagnosis 
of any ACS since it distinguishes STEMI 
from NSTEMI, and identifies any arrhythmias 
which the patient may have developed
3. Result & conclusion: the patient’s ECG 
showed right bundle branch block: QRS 
complex >120ms and RSR’ pattern in the 
anterior precordial leads V1-V3. In V1-V3, 
one can observe reciprocal ST segment 
depressions and T wave inversion, while 
there was no ST elevation in any of the leads 
(refer to figure 3). The clinical presentation 
and the raised troponins combined with 
these ECG changes led to the diagnosis of 
NSTEMI.
1. Investigation: bloods: troponins, CBC, U&E, 
ABGs, lipid profile, glucose levels, liver 
function tests
2. Justification: CBC is done to rule out any 
anaemia or infective cause, troponins are 
used as biomarkers of myocardial injury, 
ABGs are done in casualty since the patient 
was short of breath, lipid profile and HGTs 
aid assessment of cardiovascular risk 
factors such as hypercholesterolaemia and 
diabetes mellitus, U&E and liver function 
tests provide baseline organ function levels 
which must be considered when choosing 
pharmacological therapy 
3. Result & conclusion: elevated initial 
troponins and an increase of >20% in the 
3-hr repeated troponins together with the 
typical chest pain and lack of ST elevation 
on ECG indicated that the patient had 
NSTEMI, while HGTs and lipid profile 
confirmed uncontrolled diabetes mellitus 
and hypercholesterolaemia. The other tests 
showed no remarkable findings: the patient 
has adequate liver function and does not 
have chronic kidney disease. 
1. Investigation: transthoracic 
echocardiography
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2. Justification: assessment of any hypokinetic 
or akinetic areas of myocardium, assessment 
of LV ejection fraction: it has been found 
that reduced ejection fraction in NSTEMI 
patients is associated with greater mortality 
(Siddiqui and Holzmann, 2019).
3. Result & conclusion: mild concentric LVH 
indicative of long-standing hypertension, 
ejection fraction EF>55%, good LV systolic 
function, reversed mitral inflow pattern 
in keeping with impaired LV relaxation. 
Normal RV size and systolic function. The 
aortic and mitral valves showed no stenosis 
or regurgitation   No specific regional wall 
motion abnormality was reported. 
Management
1. Pharmacological Therapy
Following investigations, the patient was 
started on the following:
2. PCl
The patient’s cardiovascular risk factors (stage 
2 hypertension, smoking, diabetes mellitus, 
hypercholesterolaemia) meant that early 
invasive therapy was chosen as the preferred 
treatment pathway. (Brown et al., 2018). As 
shown in figure 4, a very tight stenosis was 
identified in the proximal LAD, and PCI was 
done on this lesion. The area was predilated 
with a 3.5x15mm balloon and stented with a 
4x18mm DES (drug-eluting stent).
3. Follow-up  
After NSTEMI, the patient is prescribed one 
year of dual antiplatelet therapy: aspirin (75mg 
once daily) and clopidogrel (75mg once daily).
Risk factor modification is another important 
issue: patient is given advice to stop smoking, 
control his diabetes, hypertension control 
and keeping LDL below 1.4mmol/L. The 
patient recovered well following PCI, and was 
discharged two days later with an outpatients 
appointment 3 months later.
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